603392 萬泰生物
按盤價 
37.930 -0.260 (-0.681%) | 2026/03 - 三個月 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -0.363 | -3.301 | 0.851 | 9.965 | 56.353 |
| 總資產報酬率 ROA (%) | -0.309 | -2.772 | 0.699 | 7.812 | 40.693 |
| 投入資產回報率 ROIC (%) | -0.351 | -3.186 | 0.821 | 9.626 | 53.875 | 邊際利潤分析 |
| 銷售毛利率 (%) | 69.858 | 49.321 | 66.196 | 84.154 | 89.536 |
| 營業利潤率 (%) | -11.213 | -25.796 | 4.179 | 25.431 | 50.031 |
| 息稅前利潤/營業總收入 (%) | -10.423 | -27.062 | 0.419 | 23.598 | 49.361 |
| 淨利潤/營業總收入 (%) | -8.577 | -22.758 | 4.859 | 22.619 | 43.480 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | -8.824 | 104.692 | -222.609 | 117.129 | 97.395 |
| 價值變動淨收益/利潤總額(%) | -33.997 | -23.813 | 216.867 | 8.867 | 0.826 |
| 營業外收支淨額/利潤總額(%) | 1.984 | 2.425 | -39.058 | -0.578 | -0.239 | 償債能力分析 |
| 流動比率 (X) | 4.212 | 4.176 | 4.162 | 3.858 | 3.495 |
| 速動比率 (X) | 3.732 | 3.786 | 3.733 | 3.519 | 3.245 |
| 資產負債率 (%) | 12.883 | 14.319 | 15.259 | 18.017 | 22.580 |
| 帶息債務/全部投入資本 (%) | 2.392 | 2.487 | 2.518 | 3.215 | 2.628 |
| 股東權益/帶息債務 (%) | 4,040.583 | 3,885.457 | 3,828.624 | 2,999.358 | 3,682.842 |
| 股東權益/負債合計 (%) | 666.829 | 589.990 | 547.096 | 448.572 | 336.767 |
| 利息保障倍數 (X) | -10.251 | 43.295 | -0.162 | -13.986 | -89.610 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 268.035 | 361.900 | 403.347 | 226.370 | 99.701 |
| 存貨周轉天數 (天) | 419.093 | 305.642 | 419.425 | 365.800 | 224.891 |
| 備註： | 即時報價更新時間為 21/05/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
